Financials

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 1,345 $ 3,640
Accounts receivable 21
Prepaid expenses and other current assets 240 517
Mortgage note receivable, current portion 1,294 1,294
Total current assets 2,879 5,472
Property and equipment, net 243 280
Deposits 31 31
In process research and development 53,905 53,905
Goodwill 65,195 65,195
Total assets 122,253 124,883
Current liabilities:    
Accounts payable and accrued expenses 901 563
Derivative liabilities 855 1,476
Total current liabilities 1,756 2,039
Long-term liabilities    
Deferred rent 37 63
Deferred tax liability 20,462 20,462
Total long-term liabilities 20,499 20,525
Total liabilities 22,255 22,564
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.001 par value; 800,000 shares authorized; 728,239 and 714,032 issued and outstanding as of September 30, 2017 and December 31, 2016, respectively 728 714
Additional paid-in capital 242,510 239,035
Accumulated deficit (143,240) (137,430)
Total stockholders' equity 99,998 102,319
Total liabilities and stockholders' equity $ 122,253 $ 124,883

Source

v3.8.0.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses        
Research and development $ 1,393 $ 2,093 $ 4,718 $ 7,803
General and administrative 717 (199) 1,712 3,630
Total operating expenses 2,110 1,894 6,430 11,433
Loss from operations (2,110) (1,894) (6,430) (11,433)
Other income (expense)        
Interest income (expense), net (2) 51 (1) 141
Change in fair value of derivative liabilities (148) (38) 621 2,173
Other income (expense), net (1)
Total other income (expense), net (150) 13 620 2,313
Loss before income taxes (2,260) (1,881) (5,810) (9,120)
Income tax expense
Net loss and comprehensive loss $ (2,260) $ (1,881) $ (5,810) $ (9,120)
Net loss per common share:        
Loss per share, basic $ (0.00) $ (0.00) $ (0.01) $ (0.01)
Weighted average common shares outstanding, basic 728,032,000 707,478,000 720,284,000 702,634,000
Loss per share, fully diluted $ (0.00) $ (0.00) $ (0.01) $ (0.02)
Weighted average common shares outstanding, diluted 728,032,000 707,478,000 720,284,000 703,417,000

Source

v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Statement of Cash Flows [Abstract]    
Net loss $ (5,810) $ (9,120)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 77 159
Stock-based compensation 409 297
Change in fair value of derivative liabilities (621) (2,173)
Change in deferred rent (14) (7)
Changes in operating assets and liabilities:    
Accounts receivable 21 16
Prepaid expenses and other current assets 277 (184)
Accounts payable and accrued expenses 338 (1,342)
Net cash used in operating activities (5,323) (12,354)
Investing activities    
Purchase of fixed assets (40) (49)
Long-term deposits (12) (23)
Principal payments received on mortgage note receivable 40
Net cash used in investing activities (52) (32)
Financing activities    
Proceeds from issuance of common stock and warrants 3,000 9,013
Proceeds from exercise of stock options 80 3
Net cash provided by financing activities 3,080 9,016
Net decrease in cash and cash equivalents (2,295) (3,370)
Cash and cash equivalents at beginning of period 3,640 9,276
Cash and cash equivalents at end of period 1,345 5,906
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Cashless exercise of warrants $ 35

Source